Literature DB >> 27326174

Risk factors for cardiovascular events and bleeding complications following non-cardiac surgery or procedure in patients with drug eluting stent placement.

Divya Tiwari1, Claudine T Jurkovitz2, Zugui Zhang2, James Bowen2, Paul Kolm2, Gail Wygant3, William S Weintraub2.   

Abstract

OBJECTIVES: Previous studies suggest an increased incidence of cardiovascular (CV) events after P2Y12 receptor blocker cessation. The aim of this study was to examine the effect of P2Y12 receptor blocker cessation and other risk factors on the risk of CV events and bleeding events after non-cardiac surgery/procedure in patients with drug-eluting stents (DES).
DESIGN: Retrospective cohort study.
SETTING: Single large healthcare system in the northeast of the USA. PATIENTS: All adult patients who had a coronary drug eluting stent (DES) placed between 2002 and 2007 in our institution.
INTERVENTIONS: No randomised intervention. The principal exposure was cessation of P2Y12 receptor blocker.
METHODS: This was a retrospective study of all adult patients who had a coronary DES placed between 2002 and 2007 in our institution. We considered all non-cardiac procedures up to 1 year after DES placement. Generalised estimating equations were used to identify the independent risk factors. Multiple imputations were used to replace missing values. MAIN OUTCOME MEASURES: The outcomes were CV events including death from any cause and bleeding, occurring within 30 days after the procedure.
RESULTS: From 2002 to 2007, 6397 patients had DES, 873 (13.6%) had at least one non-cardiac procedure. A total of 3.6% (33/927) of the admissions were complicated by at least one cardiovascular event and 6.9% (55/795) were complicated by bleeding. Urgent procedure (versus elective) was the only independent risk factor for CV events (OR=4.82, 95% CI 1.95 to 11.89). Older age, diabetes, urgent procedures, orthopaedic and vascular surgery compared to unclassified surgery were independent risk factors for bleeding.
CONCLUSIONS: Non-cardiac procedures are common within 1 year after DES placement. Urgent nature of procedure is a risk factor for CV events and bleeding complications. Older age, diabetes, type of surgery, are risk factors associated only with bleeding events.

Entities:  

Keywords:  Heart Failure; Interventional Cardiology

Year:  2014        PMID: 27326174      PMCID: PMC4832717          DOI: 10.1136/heartasia-2013-010471

Source DB:  PubMed          Journal:  Heart Asia        ISSN: 1759-1104


  19 in total

1.  Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.

Authors:  Matthias Pfisterer; Hans Peter Brunner-La Rocca; Peter T Buser; Peter Rickenbacher; Patrick Hunziker; Christian Mueller; Raban Jeger; Franziska Bader; Stefan Osswald; Christoph Kaiser
Journal:  J Am Coll Cardiol       Date:  2006-11-02       Impact factor: 24.094

2.  Risk of noncardiac surgery after coronary drug-eluting stent implantation.

Authors:  P Alexander Compton; Ahmad A Zankar; Adebola O Adesanya; Subhash Banerjee; Emmanouil S Brilakis
Journal:  Am J Cardiol       Date:  2006-09-07       Impact factor: 2.778

Review 3.  Adverse cardiac events in patients with coronary stents undergoing noncardiac surgery: a systematic review.

Authors:  Robert H Hollis; Laura A Graham; Joshua S Richman; Rhiannon J Deierhoi; Mary T Hawn
Journal:  Am J Surg       Date:  2012-08-04       Impact factor: 2.565

4.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

5.  Coronary artery stenting and non-cardiac surgery--a prospective outcome study.

Authors:  M N Vicenzi; T Meislitzer; B Heitzinger; M Halaj; L A Fleisher; H Metzler
Journal:  Br J Anaesth       Date:  2006-05-02       Impact factor: 9.166

6.  Catastrophic outcomes of noncardiac surgery soon after coronary stenting.

Authors:  G L Kałuza; J Joseph; J R Lee; M E Raizner; A E Raizner
Journal:  J Am Coll Cardiol       Date:  2000-04       Impact factor: 24.094

Review 7.  Efficacy and safety of drug-eluting stents in chronic total coronary occlusion recanalization: a systematic review and meta-analysis.

Authors:  Humberto J Colmenarez; Javier Escaned; Cristina Fernández; Liliana Lobo; Sara Cano; Juan G del Angel; Fernando Alfonso; Pilar Jimenez; Camino Bañuelos; Nieves Gonzalo; Eulogio García; Rosana Hernández; Carlos Macaya
Journal:  J Am Coll Cardiol       Date:  2010-04-27       Impact factor: 24.094

8.  Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents.

Authors:  Mary T Hawn; Laura A Graham; Joshua S Richman; Kamal M F Itani; William G Henderson; Thomas M Maddox
Journal:  JAMA       Date:  2013-10-09       Impact factor: 56.272

9.  Drug-eluting stent thrombosis in patients undergoing non-cardiac surgery: is it always a problem?

Authors:  G Godet; Y Le Manach; F Lesache; S Perbet; P Coriat
Journal:  Br J Anaesth       Date:  2008-03-01       Impact factor: 9.166

10.  Discontinuation of antiplatelet therapy prior to low-risk noncardiac surgery in patients with drug-eluting stents: a retrospective cohort study.

Authors:  Daniel J Brotman; Mihir Bakhru; Wael Saber; Ashish Aneja; Deepak L Bhatt; Katherina Tillan-Martinez; Amir K Jaffer
Journal:  J Hosp Med       Date:  2007-11       Impact factor: 2.960

View more
  1 in total

1.  The efficacy and safety of dexmedetomidine in cardiac surgery patients: A systematic review and meta-analysis.

Authors:  Guobin Wang; Jianhua Niu; Zhitao Li; Haifeng Lv; Hongliu Cai
Journal:  PLoS One       Date:  2018-09-19       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.